Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis

This publication has 20 references indexed in Scilit:

• New therapies for rheumatoid arthritis
  Clinical and Experimental Immunology, 2005
• Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2004
• Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases
  Annals of the Rheumatic Diseases, 2004
• Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study
  Arthritis & Rheumatism, 2004
• Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis
  Clinical and Experimental Immunology, 2003
• Clinical utility of the anti-CCP assay in patients with rheumatic diseases
  Annals of the Rheumatic Diseases, 2003
• Identification of citrullinated rheumatoid arthritis‐specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay
  Arthritis & Rheumatism, 2002
• Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
  Journal of Clinical Investigation, 1998
• Natural IgG to epidermal cytokeratins vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called ‘antikeratin antibodies’, in rheumatoid arthritis and other rheumatic diseases
  Journal of Autoimmunity, 1991
• The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
  Arthritis & Rheumatism, 1988